Orthotopic bladder substitution: Surgical aspects and optimization of outcomes.

bladder substitution cystectomy neobladder orthotopic bladder substitute urinary diversion

Journal

BJUI compass
ISSN: 2688-4526
Titre abrégé: BJUI Compass
Pays: United States
ID NLM: 101764975

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 27 12 2020
revised: 07 03 2021
accepted: 07 03 2021
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 28 4 2022
Statut: epublish

Résumé

Orthotopic bladder substitution (OBS) is a management option for urinary diversion in men and women undergoing cystectomy. The aim of the procedure is to provide a functional continent urinary reservoir of adequate capacity, compliance and low pressure. We have provided a narrative review of the existing literature and highlighted areas where improvement and standardization can be recommended. Literature search included database search for publications from January 1970 to November 2020, using keywords including OBS, bladder reconstruction, neobladder, radical cystectomy, robotic cystectomy, intracorporeal neobladder, surgical technique, patient selection and outcomes. Due to various factors including indications, operative technique and risk of complications, OBS is an enormous undertaking and commitment for patients, surgeons and health professionals involved in the care pathway. The main considerations for patient selection, the technical elements of the procedure and the rationale behind these are discussed. Previously considered to be a choice for a select few, the inclusion criteria have expanded over the last decade. Similarly, surgical techniques including the choice and configuration of bowel segments, construction of anastomosis and nerve or organ sparing procedures have evolved over the years. Minimally invasive laparoscopic and robotic assisted surgery has added further perspectives to the existing literature on OBS. Understanding the principles of operative techniques and assessing the best evidence to influence patient management is crucial as it has a major impact on clinical outcomes. Peri- and post-operative care, focused on the prevention of complications and morbidity, affects long-term functional and oncological outcomes, which ultimately dictates the quality of life. This concise overview of OBS literature highlights the importance of pre-operative, peri-operative, and post-operative aspects with regards to the optimization of patient care. To achieve the best results, meticulous attention should be paid in all these areas, surgical and multi-disciplinary. Patient education and counseling, with shared decision making are central to the success of the procedure.

Identifiants

pubmed: 35474698
doi: 10.1002/bco2.84
pii: BCO284
pmc: PMC8988640
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

359-369

Informations de copyright

© 2021 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.

Déclaration de conflit d'intérêts

None.

Références

Cancer. 2001 Oct 1;92(7):1864-71
pubmed: 11745259
BJUI Compass. 2021 Sep 02;2(6):359-369
pubmed: 35474698
J Urol. 2002 Jul;168(1):164-7
pubmed: 12050514
BJU Int. 2006 May;97(5):1057-62
pubmed: 16643492
Eur Urol. 2005 May;47(5):666-72; discussion 672-3
pubmed: 15826760
Urology. 2011 Apr;77(4):878-83
pubmed: 21215428
Scand J Urol Nephrol. 2008;42(4):344-51
pubmed: 19230167
World J Urol. 2012 Dec;30(6):733-9
pubmed: 22322390
J Urol. 2019 May;201(5):909-915
pubmed: 30694935
BJU Int. 2009 Mar;103(5):680-3
pubmed: 19076133
Urology. 2009 Dec;74(6):1331-9
pubmed: 19800669
J Urol. 2009 May;181(5):2052-8; discussion 2058-9
pubmed: 19286213
Curr Urol. 2019 Sep;13(1):37-45
pubmed: 31579223
J Urol. 2008 Feb;179(2):582-6
pubmed: 18078958
Urol Clin North Am. 1992 Nov;19(4):713-23
pubmed: 1279876
BJU Int. 2004 Jan;93(1):183-93
pubmed: 14678400
J Urol. 1998 Jul;160(1):29-33
pubmed: 9628599
J Urol. 2020 Jan;203(1):159-163
pubmed: 31441673
Eur Urol. 2012 Aug;62(2):290-302
pubmed: 22609313
Eur J Surg Oncol. 2016 Mar;42(3):343-60
pubmed: 26620844
BJU Int. 2020 Feb;125(2):253-259
pubmed: 31220396
J Urol. 1995 Dec;154(6):2044-9
pubmed: 7500455
Nat Rev Urol. 2014 Aug;11(8):437-44
pubmed: 25023593
Int Urol Nephrol. 2011 Sep;43(3):749-54
pubmed: 21053073
Urology. 2008 May;71(5):919-23
pubmed: 18355900
Eur J Surg Oncol. 2013 Apr;39(4):358-64
pubmed: 23422323
BJU Int. 2004 Dec;94(9):1317-21
pubmed: 15610113
J Urol. 2002 Oct;168(4 Pt 1):1442-5
pubmed: 12352414
Urol Clin North Am. 2018 Feb;45(1):67-77
pubmed: 29169452
J Urol. 2005 Nov;174(5):1944-7
pubmed: 16217363
BMJ Open. 2018 Aug 8;8(8):e020500
pubmed: 30093510
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003306
pubmed: 22336788
BJU Int. 2006 Apr;97(4):799-804
pubmed: 16536777
Eur Urol. 2016 Feb;69(2):247-53
pubmed: 26164417
J Urol. 2005 Nov;174(5):1729-36
pubmed: 16217273
Urology. 2007 Jan;69(1 Suppl):17-49
pubmed: 17280907
BJU Int. 2003 Apr;91(6):485-8
pubmed: 12656899
Ann R Coll Surg Engl. 2009 Oct;91(7):565-9
pubmed: 19558757
Urol Oncol. 2018 Feb;36(2):54-59
pubmed: 29196179
Eur Urol. 2013 Jan;63(1):67-80
pubmed: 22995974
Eur Urol. 2011 Nov;60(5):1066-73
pubmed: 21852033
Urol Oncol. 2017 Sep;35(9):539.e17-539.e29
pubmed: 28495555
J Urol. 2005 Apr;173(4):1163-8
pubmed: 15758728
Eur Urol. 2009 Jan;55(1):164-74
pubmed: 18675501
Semin Urol Oncol. 2001 Feb;19(1):18-23
pubmed: 11246729
J Urol. 1988 Mar;139(3):519-23
pubmed: 3343736
Int Braz J Urol. 2013 Jul-Aug;39(4):474-83
pubmed: 24054377
Int J Urol. 2007 Feb;14(2):112-7
pubmed: 17302566
J Urol. 1996 Nov;156(5):1615-9
pubmed: 8863551
BJU Int. 2018 Jun;121(6):935-944
pubmed: 29319917
J Clin Oncol. 2014 Oct 10;32(29):3291-8
pubmed: 25185104
Eur Urol. 2011 Dec;60(6):1266-72
pubmed: 21871713
J Urol. 1996 Dec;156(6):1913-7
pubmed: 8911354
J Urol. 2004 Sep;172(3):937-42
pubmed: 15311003
World J Urol. 2009 Feb;27(1):57-62
pubmed: 19020883
Urology. 2006 Apr;67(4):742-5
pubmed: 16566975
World J Urol. 2012 Dec;30(6):741-5
pubmed: 22457033
Urology. 2008 Jul;72(1):162-6
pubmed: 18372008
Eur Urol. 2010 Sep;58(3):374-83
pubmed: 20605317
World J Urol. 2000 Oct;18(5):338-44
pubmed: 11131311
Urology. 2004 Nov;64(5):950-4
pubmed: 15533484
J Urol. 2008 Jul;180(1):164-7; discussion 167
pubmed: 18485384
Eur Urol. 2015 Mar;67(3):423-31
pubmed: 25595099
J Urol. 2000 Jul;164(1):10-3
pubmed: 10840413
Urology. 2009 Apr;73(4):838-43; discussion 843-4
pubmed: 19193426
World J Urol. 2006 Aug;24(3):305-14
pubmed: 16830152
J Urol. 2018 May;199(5):1302-1311
pubmed: 29275112
J Urol. 2007 Sep;178(3 Pt 1):756-60
pubmed: 17631333
J Urol. 2006 Jul;176(1):161-6
pubmed: 16753394
Eur J Surg Oncol. 2015 Mar;41(3):295-9
pubmed: 24913090
J Urol. 2004 Oct;172(4 Pt 1):1323-7
pubmed: 15371833
Urol Clin North Am. 2005 May;32(2):177-85
pubmed: 15862615
J Urol. 2002 Feb;167(2 Pt 1):502-5
pubmed: 11792906
Urol Oncol. 2019 Mar;37(3):180.e1-180.e9
pubmed: 30482434
Lancet. 2018 Jun 23;391(10139):2525-2536
pubmed: 29976469
Urol Clin North Am. 1997 Feb;24(1):225-39
pubmed: 9048863
J Urol. 1997 Jun;157(6):2266
pubmed: 9146648
Curr Urol Rep. 2016 Jun;17(6):42
pubmed: 27021910
BJU Int. 2014 Sep;114(3):375-83
pubmed: 24467630
J Urol. 2014 Mar;191(3):619-25
pubmed: 24036234
World J Urol. 2016 Jan;34(1):13-8
pubmed: 26410825
Urology. 2004 Jun;63(6):1153-7
pubmed: 15183970
Cancer. 2006 Jun 1;106(11):2355-62
pubmed: 16649218
BJU Int. 2017 Jul;120(1):12-24
pubmed: 28220653
Indian J Urol. 2014 Jul;30(3):307-13
pubmed: 25097318
World J Surg Oncol. 2015 Jan 06;13:3
pubmed: 25560783

Auteurs

N Thakare (N)

Department of Urology Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital Cambridge UK.

B W Lamb (BW)

Department of Urology Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital Cambridge UK.
Faculty of Health, Education, Medicine and Social Care Anglia Ruskin University Chelmsford UK.

S Biers (S)

Department of Urology Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital Cambridge UK.
Faculty of Health, Education, Medicine and Social Care Anglia Ruskin University Chelmsford UK.

Classifications MeSH